NBC Securities Inc. Trims Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

NBC Securities Inc. reduced its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,665 shares of the exchange traded fund’s stock after selling 175 shares during the quarter. NBC Securities Inc.’s holdings in SPDR S&P Biotech ETF were worth $537,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 35.9% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock valued at $214,832,000 after buying an additional 635,000 shares during the last quarter. Phoenix Holdings Ltd. lifted its stake in SPDR S&P Biotech ETF by 0.8% during the third quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock worth $157,092,000 after purchasing an additional 17,221 shares during the last quarter. MBB Public Markets I LLC lifted its stake in SPDR S&P Biotech ETF by 67.0% during the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock worth $37,562,000 after purchasing an additional 206,337 shares during the last quarter. Finally, Employees Retirement System of Texas bought a new position in SPDR S&P Biotech ETF during the third quarter worth $27,456,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $89.92 on Friday. The business’s fifty day moving average price is $89.06 and its 200 day moving average price is $90.17. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The stock has a market capitalization of $6.85 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.